Novartis Ag NVS
NYSE NVS
$158.86 +2.62 (+1.68%)
At close: Aug 21, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Profit After Tax (2009 - 2026)

Novartis Ag (NVS) posted Profit After Tax of $3.3 billion for Q2 2026, down 19.06% sequentially from $4.0 billion in Q2 2025, and down 19.06% YoY from $4.0 billion in Q2 2025.

Novartis Ag (NVS) Profit After Tax (2009 - 2026) Analysis & Trends

Novartis Ag has reported Profit After Tax for 18 years, with the latest figure at $3.3 billion in Q2 2026.

  • Quarterly Profit After Tax fell 19.06% year-over-year to $3.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $16.5 billion (down 7.6% YoY) and the FY2025 annual result came in at $14.0 billion, up 16.99% from the prior year.
  • Profit After Tax declined to $3.3 billion in Q2 2026 per NVS's latest filing, from $4.0 billion in the prior quarter.
  • Over five years, Profit After Tax peaked at $34001.4 billion in Q1 2022 and troughed at $1.1 billion in Q3 2022.
  • A 5-year average of $3548.4 billion and a median of $3.9 billion in 2022 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2022 and 2023: Profit After Tax surged 142.84% in 2022, then tumbled 85.29% in 2023.
  • Over 5 years, Profit After Tax stood at $3.9 billion in 2022, then rose by 17.81% to $4.6 billion in 2023, then gained by 28.69% to $5.9 billion in 2024, then tumbled by 32.19% to $4.0 billion in 2025, then slipped by 19.06% to $3.3 billion in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered $3.3 billion, $4.0 billion, and $5.9 billion for Q2 2026, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 5.53 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 3.62 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 2.51 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -10.50 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -248.00 Mn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 207.96 Mn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 438.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.26 Bn
Jun 30, 2025 4.02 Bn
Dec 31, 2024 5.93 Bn
Jun 30, 2024 3.25 Bn
Dec 31, 2023 4.61 Bn
Jun 30, 2023 2.32 Bn
Mar 31, 2023 5,001.33 Bn
Dec 31, 2022 3.91 Bn
Sep 30, 2022 1.14 Bn
Jun 30, 2022 1.70 Bn
Mar 31, 2022 34,001.37 Bn
Dec 31, 2021 4.95 Bn
Sep 30, 2021 1.40 Bn
Jun 30, 2021 2.90 Bn
Mar 31, 2021 14,001.31 Bn
Dec 31, 2020 4.04 Bn
Sep 30, 2020 18,001.39 Bn
Jun 30, 2020 1.87 Bn
Mar 31, 2020 194.00 Mn
Jun 30, 2019 6.80 Bn